- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01845909
Sudden Cardiac Death - Screening Of Risk Factors (SCD-SOS)
Sudden Cardiac Death: Evaluation of a New Strategy to Identify Young Adults at Risk
The investigators have created a way of quickly collecting information in a large scale young population regarding the presence of some severity indicators that may allow us to classify them into: seemingly "low risk" and possible "elevated risk" for the presence of heart disease. It would have to be a short questionnaire, in order to receive a great adherence but that could simultaneously provide precise information, with an adequate description of symptoms and warning signs, in a way that a triage in the young adult population could be performed in the general young adult population in order to select individuals with an indication for personalized clinical evaluation and possible need of complementary diagnostic means. Based on this premise the investigators have developed a fast-response questionnaire named the Sudden Cardiac Death Screening Of risk factorS (SCD-SOS). This questionnaire has already been tested in a population of approximately 1500 young adults, and some changes have been introduced in order to refine its performance.
To best of the investigators knowledge, there are no large scale European surveys estimating the prevalence of cardiac disease and associated clinical symptoms in a non-selected (non-athlete) population of this age group.
Purpose: To screen a young adult population from central regional of Portugal for heart disease possibly associated to a high risk of Sudden Cardiac Death (SCD).
To determine the national prevalence of clinical symptoms of heart disease and of heart disease with increased risk for SCD in this age group.
To detect young adults in risk of SCD and with an indication for evaluation by a cardiologist, and possible need of:
- medical treatment
- electrophysiologic (EP) study and percutaneous ablation
- an implantable cardiovertor defibrillator
- a pacemaker
- other type of specialized cardiac intervention
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
State...
-
Coimbra, State..., Portugal, 3000
- Unidade Móvel - Tenda de Rastreio - SCDSOS
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- 12 to 40 years of age
- Providing an informed consent
Exclusion Criteria:
- Failure to meet any of the aforementioned inclusion criteria
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
young adults - Central region of Portugal
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Type 1 electrocardiogram
Time Frame: baseline
|
Presence of ECG changes suggestive of cardiac disease associated with an increased risk of sudden cardiac death. Definition present in: Corrado D et al. Recommendations for interpretation of 12-lead electrocardiogram in the athlete. Eur Heart J 2010;31:243-259 |
baseline
|
|
Clinical History - Red Flag
Time Frame: Baseline
|
Presence of answers concerning symptoms or past family history that are known to be associated with increased risk of sudden cardiac death: e.g. effort syncope, syncope with fast palpitations prodrome, know high-risk cardiac disease, history of sudden cardiac death in first or second degree relative |
Baseline
|
|
all-cause mortality
Time Frame: First 20 years after enrollement
|
occurrence of death of any cause in the participant
|
First 20 years after enrollement
|
|
Cardiovascular death
Time Frame: First 20 years after enrollement
|
Occurrence of death of cardiovascular etiology during follow-up.
|
First 20 years after enrollement
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Chair: Rui Providência, M.D. M.Sc., Coimbra's Hospital Centre and University; Faculty of Medicine, University of Coimbra, Portugal
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SCD-SOS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cardiomyopathies
-
St. Jude Children's Research HospitalActive, not recruitingChildhood Cancer | Cardiomyopathy, PrimaryUnited States
-
Yale UniversityPfizerCompletedCardiomyopathies, PrimaryUnited States
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingCardiomyopathy | Hypertrophic Cardiomyopathies
-
Nantes University HospitalUniversity Hospital, Angers; University Hospital, Brest; University Hospital,...Recruiting
-
Shandong Suncadia Medicine Co., Ltd.Recruiting
-
Shandong Suncadia Medicine Co., Ltd.Completed
-
Tanta UniversityDelta University for Science and TechnologyNot yet recruiting
-
Oregon Health and Science UniversityNot yet recruiting
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
University of VirginiaGE HealthcareNot yet recruiting
Clinical Trials on ECG and survey screening
-
RenJi HospitalRecruitingPublic Health | Public Health System Research | Multi-system Disease DiagnosisChina
-
Mayo ClinicCompleted
-
Monash UniversityNational Health and Medical Research Council, Australia; Curtin UniversityActive, not recruitingHeart Failure | Atrial Fibrillation | Hypercholesterolemia | Healthy Ageing | Myocardial DysfunctionAustralia
-
Karolinska University HospitalRoche DiagnosticsActive, not recruiting
-
Massachusetts General HospitalEnrolling by invitationAtrial Fibrillation (AF)United States
-
Foundation for Sarcoidosis ResearchCompletedSarcoidosis | Cardiac Sarcoidosis | Boeck's Disease | Besnier-Boeck DiseaseUnited States, United Kingdom, Netherlands
-
Karolinska University HospitalUnknownStroke | Atrial FibrillationSweden
-
Indiana University School of MedicineMuscular Dystrophy AssociationCompletedMuscular Dystrophy | Arrhythmia | Sudden Cardiac DeathUnited States
-
National Defense Medical Center, TaiwanCompletedLeft Ventricular Systolic Dysfunction (Disorder)Taiwan